# Tango Therapeutics, Inc.: Form DEF 14A, filed Apr 17, 2026

- Company: [Tango Therapeutics, Inc.](/companies/tngx.md) (CIK 1819133)
- Form: DEF 14A
- Filed: 2026-04-17
- Accepted by EDGAR: Apr 17, 2026, 07:12 ET
- Period: 2026-04-16
- Accession: 0001193125-26-160287
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1819133/000119312526160287/tngx-20260416.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1819133/000119312526160287/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1819133/000119312526160287/tngx-20260416.htm

Filed Apr 17, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-160287. Last ingested by Listed: Nov 15, 2026, 01:16 ET. No prices; not investment advice.
